[Two cases of obstructive jaundice due to extrahepatic carcinoma of the bile duct with marked response to daily oral administration of etoposide].
Two cases of obstructive jaundice due to cancer of extrahepatic bile duct were treated with a combination chemotherapy combined with etoposide. The first case was a 81-year-old male and the second case was a 62-year-old female who introduced to this hospital because of jaundice and admitted. Cholangiography was performed and diagnosed cancer of the extrahepatic bile duct. Daily oral administration of etoposide (25mg/day) added to other immunochemotherapy was carried out. The cholangiography via PTCD tube revealed a passage of obstruction of the choledochus. These data suggest that a combination chemotherapy including oral administration of etoposide was effective in these two cases.
Shibata
T
T
Dept. of Surgery, Megumino Hospital.
Sato
T
T
Kondo
H
H
Ootani
I
I
Suzuki
H
H
Kawada
S
S
D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001651:Cholestasis, Extrahepatic / Q000209:etiology*; D003138:Common Bile Duct Neoplasms / Q000150:complications / Q000188:drug therapy*; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005467:Floxuridine / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D010844:Picibanil / Q000008:administration & dosage; D012074:Remission Induction; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D005467:Floxuridine; D005641:Tegafur; D010844:Picibanil; D014498:Uracil; D005047:Etoposide; C025034:doxifluridine